Mostrar el registro sencillo del ítem

dc.contributor.authorHarris, Simon R
dc.contributor.authorCole, Michelle J
dc.contributor.authorSpiteri, Gianfranco
dc.contributor.authorSánchez-Busó, Leonor
dc.contributor.authorGolparian, Daniel
dc.contributor.authorJacobsson, Susanne
dc.contributor.authorGoater, Richard
dc.contributor.authorAbudahab, Khalil
dc.contributor.authorYeats, Corin A
dc.contributor.authorBercot, Beatrice
dc.contributor.authorBorrego, Maria José
dc.contributor.authorCrowley, Brendan
dc.contributor.authorStefanelli, Paola
dc.contributor.authorTripodo, Francesco
dc.contributor.authorAbad, Raquel 
dc.contributor.authorAanensen, David M
dc.contributor.authorUnemo, Magnus
dc.contributor.authorEuro-GASP study group
dc.date.accessioned2022-03-30T07:23:46Z
dc.date.available2022-03-30T07:23:46Z
dc.date.issued2018-07
dc.identifier.citationLancet Infect Dis. 2018 Jul;18(7):758-768.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/13900
dc.description.abstractBackground: Traditional methods for molecular epidemiology of Neisseria gonorrhoeae are suboptimal. Whole-genome sequencing (WGS) offers ideal resolution to describe population dynamics and to predict and infer transmission of antimicrobial resistance, and can enhance infection control through linkage with epidemiological data. We used WGS, in conjunction with linked epidemiological and phenotypic data, to describe the gonococcal population in 20 European countries. We aimed to detail changes in phenotypic antimicrobial resistance levels (and the reasons for these changes) and strain distribution (with a focus on antimicrobial resistance strains in risk groups), and to predict antimicrobial resistance from WGS data. Methods: We carried out an observational study, in which we sequenced isolates taken from patients with gonorrhoea from the European Gonococcal Antimicrobial Surveillance Programme in 20 countries from September to November, 2013. We also developed a web platform that we used for automated antimicrobial resistance prediction, molecular typing (N gonorrhoeae multi-antigen sequence typing [NG-MAST] and multilocus sequence typing), and phylogenetic clustering in conjunction with epidemiological and phenotypic data. Findings: The multidrug-resistant NG-MAST genogroup G1407 was predominant and accounted for the most cephalosporin resistance, but the prevalence of this genogroup decreased from 248 (23%) of 1066 isolates in a previous study from 2009-10 to 174 (17%) of 1054 isolates in this survey in 2013. This genogroup previously showed an association with men who have sex with men, but changed to an association with heterosexual people (odds ratio=4·29). WGS provided substantially improved resolution and accuracy over NG-MAST and multilocus sequence typing, predicted antimicrobial resistance relatively well, and identified discrepant isolates, mixed infections or contaminants, and multidrug-resistant clades linked to risk groups. Interpretation: To our knowledge, we provide the first use of joint analysis of WGS and epidemiological data in an international programme for regional surveillance of sexually transmitted infections. WGS provided enhanced understanding of the distribution of antimicrobial resistance clones, including replacement with clones that were more susceptible to antimicrobials, in several risk groups nationally and regionally. We provide a framework for genomic surveillance of gonococci through standardised sampling, use of WGS, and a shared information architecture for interpretation and dissemination by use of open access software.es_ES
dc.description.sponsorshipThis study was supported by the European Centre for Disease Prevention and Control, The Centre for Genomic Pathogen Surveillance, the Wellcome Genome Campus, the Foundation for Medical Research at Örebro University Hospital, and grants from Wellcome (098051 and 099202).es_ES
dc.language.isoenges_ES
dc.publisherElsevier es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdult es_ES
dc.subject.meshAnti-Bacterial Agents es_ES
dc.subject.meshAzithromycin es_ES
dc.subject.meshBacterial Typing Techniques es_ES
dc.subject.meshCeftriaxone es_ES
dc.subject.meshCiprofloxacin es_ES
dc.subject.meshDrug Resistance, Multiple, Bacterial es_ES
dc.subject.meshEurope es_ES
dc.subject.meshFemale es_ES
dc.subject.meshGenotype es_ES
dc.subject.meshGonorrhea es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshMicrobial Sensitivity Tests es_ES
dc.subject.meshMolecular Epidemiology es_ES
dc.subject.meshMultilocus Sequence Typing es_ES
dc.subject.meshNeisseria gonorrhoeae es_ES
dc.subject.meshPhylogeny es_ES
dc.subject.meshPublic Health Surveillance es_ES
dc.subject.meshWhole Genome Sequencing es_ES
dc.subject.meshYoung Adult es_ES
dc.titlePublic health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic surveyes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID29776807es_ES
dc.format.volume18es_ES
dc.format.number7es_ES
dc.format.page758-768es_ES
dc.identifier.doi10.1016/S1473-3099(18)30225-1es_ES
dc.contributor.funderUnión Europea. European Centre for Disease Prevention and Control (ECDC) es_ES
dc.contributor.funderCentre for Genomic Pathogen Surveillance es_ES
dc.contributor.funderÖrebro University Hospital (Suecia)es_ES
dc.contributor.funderWellcome Trust es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1474-4457es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/S1473-3099(18)30225-1es_ES
dc.identifier.journalThe Lancet. Infectious Diseaseses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional